- World rank, all time
- #40,208 of 42,892
- Rank in India
- #1,943 of 2,075
- Research works
- 126 ▲ 23% vs 2013–17
- Citations
- 1.7k 13.3 per fractional work
- Top-10% rate
- 13.1% record average 16.5%
- Open access
- 50% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.8×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 6.8×
- Immunology and Microbiology 6.1×
- Chemistry 4.9×
- Nursing 2.8×
- Medicine 2.2×
- Biochemistry, Genetics and Molecular Biology 1.7×
- Environmental Science 1.2×
- Health Professions 0.9×
- Social Sciences 0.8×
- Decision Sciences 0.6×
- Materials Science 0.5×
- Mathematics 0.5×
- Agricultural and Biological Sciences 0.4×
- Engineering 0.3×
- Physics and Astronomy 0.2×
- Psychology 0.2×
- Economics, Econometrics and Finance 0.1×
- Computer Science 0.1×
- Business, Management and Accounting 0.1×
Which keywords describe research at Cadila Pharmaceuticals (India)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Inflammation, Epidemiology, Angiogenesis, Cell Adhesion, Integrins, Immune Response and Tumor Microenvironment.
- Indoor Air Pollution
- Household Fuel Use
- Tumor Microenvironment
- Integrins
- Angiogenesis
- Epidemiology
- Cancer
- Inflammation
- Cell Adhesion
- Immune Response
- Exclusionary Rule
- Human Rights Act
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 12 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 12 words, with their numbers
- Cancer3▲ 12×11 topics
- Epidemiology2▲ 3.1×8 topics
- Inflammation2▲ 5.3×7 topics
- Angiogenesis2▲ 23×2 topics
- Cell Adhesion2▲ 171×1 topic
- Integrins2▲ 301×1 topic
- Immune Response1▲ 10×2 topics
- Tumor Microenvironment1▲ 12×3 topics
- Exclusionary Rule1▲ 562×1 topic
- Household Fuel Use1▲ 67×1 topic
- Human Rights Act1▲ 562×1 topic
- Indoor Air Pollution1▲ 67×1 topic
Which research topics does Cadila Pharmaceuticals (India) publish most on?
By volume in 2022–2025: Cell Adhesion Molecules Research, Energy and Environment Impacts, Criminal Law and Evidence and COVID-19 Clinical Research Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cell Adhesion Molecules Research Immunology and Allergy 2 works
- 2 Energy and Environment Impacts Pollution 1 works
- 3 Criminal Law and Evidence Law 1 works
- 4 COVID-19 Clinical Research Studies Infectious Diseases 1 works
- 5 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 6 Biosimilars and Bioanalytical Methods Immunology 0 works
- 7 Tuberculosis Research and Epidemiology Infectious Diseases 0 works
- 8 Immune responses and vaccinations Immunology 0 works
- 9 Mycobacterium research and diagnosis Epidemiology 0 works
- 10 Sepsis Diagnosis and Treatment Epidemiology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Cadila Pharmaceuticals (India)'s research output changed?
Output in 2018–2022 was 23% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Ahmedabad
- Gujarat University
- Nirma University
- Physical Research Laboratory
- B.J. Medical College
- St Xavier’s College
- Indian Institute of Management Ahmedabad
- Government Dental College and Hospital
- National Institute of Pharmaceutical Education and Research - Ahmedabad
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.